Smart Insulin Nanostructures Pass Feasibility Test, UT Study ReportsSeptember 21, 2007Biomedical engineers at The University of Texas School of Health Information Sciences at Houston have announced pre-clinical test results in the September issue of the International Journal of Nanomedicine demonstrating the feasibility of a smart particle insulin release system that detects spikes in glucose or blood sugar levels and releases insulin to counteract them. Designed to mimic functions of the pancreas which produces the blood-sugar regulating hormone insulin, the smart particle system stabilized blood sugar levels in animal models with suppressed pancreatic functions for up to six hours, researchers reported. It is an inhalable system. The study, "Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats," was conducted in the laboratory of Ananth V. Annapragada, Ph.D., an associate professor at the UT School of Health Information Sciences. Research assistant Efstathios Karathanasis was lead author and postdoctoral fellow Rohan C. Bhavane was a contributor on the article.
The smart particle system consists of a blood sugar sensing protein named concanavalin A (Con A) and bundles of tiny fat bubbles called liposomes that are loaded with insulin. "Con A binds insulin-containing liposomes that are coated with sugars, to each other, to form the inhaled particles," Annapragada said. "When blood sugar becomes present, the Con A releases the particles to bind independently to the sugars. The released particles then release their insulin." Hundreds of thousands of individuals suffer Type I diabetes, a condition that develops when the body's immune system destroys pancreatic beta cells - the only cells that make insulin. High blood sugar levels can lead to serious complications and premature death. "No one had ever shown that an inhalable smart release system was viable," said Annapragada, who describes the study as a "proof of concept" initiative. He said additional work - including the discovery of less inflammatory blood sugar sensing proteins or small molecules - will be required before its efficacy for patients can be tested in clinical trials. The smart particle system could potentially treat other health conditions, he said. The article in the International Journal of Nanomedicine is available online at: http://www.dovepress.com/articles.php?content_id=1152 Smart particle research is supported by the Whitaker Foundation Bioengineering Research Grant and the Gillson-Longenbaugh Foundation. The University of Texas School of Health Information Sciences at Houston | |||||||||||||||||||||
|
Related Insulin Current Events and Insulin News Articles Pure insulin-producing cells produced in mouse Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs). Researcher tricks immune system in diabetic mice The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it. Systems biology brings hope of speeding up drug development Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade. Garlic chemical tablet treats diabetes I and II A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says. New insight into the controls on a go-to enzyme Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains. Vitamin C lowers levels of heart disease biomarker, finds study, adds to debate of health benefits A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes. New hybrid plants could prompt more prodigious pepper production in Southwest By themselves or as an ingredient in a variety of foods, including salsa, America's top-selling condiment, peppers have found a warm spot in the hearts and stomachs of U.S. consumers. Drug mimics low-cal diet to ward off weight gain, boost running endurance A drug designed to specifically hit a protein linked to the life-extending benefits of a meager diet can essentially trick the body into believing food is scarce even when it isn't, suggests a new report in the November Cell Metabolism. Apelin hormone injections powerfully lower blood sugar By injecting a hormone produced by fat and other tissues into mice, researchers report in the November Cell Metabolism that they significantly lowered blood sugar levels in normal and obese mice. An Anti-Frailty Pill for Seniors? Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty. More Insulin Current Events and Insulin News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||